Skip to main content

Advertisement

SpringerLink
Log in

Clinical value of 18F-fluorodeoxyglucose positron emission tomography in patients with connective tissue disease

  • Pictorial Essay
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

Abstract

Connective tissue diseases represent a heterogeneous group of immunologically mediated inflammatory disorders with a large variety of affected organs other than the lung. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) is widely used in oncology but may also be valuable in patients with infections or inflammatory disease. The purpose of this article was to assess the clinical value of 18F-FDG PET in patients with connective tissue disease. Our experience demonstrates that 18F-FDG PET is a unique imaging technique for assessing the metabolic activity throughout the body in those with a connective tissue disease. The technique appears to be a promising imaging modality for detecting coexistent neoplastic diseases and other autoimmune disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Klemperer P, Pollack AD, Baehr G. Diffuse collagen disease: acute disseminated lupus erythematosus and diffuse scleroderma. JAMA 1942;119:331–332.

    Google Scholar 

  2. Santiago Restrepo C, Gimenez CR, McCarthy K. Imaging of osteomyelitis and musculoskeletal soft tissue infections: current concepts. Rheum Dis Clin North Am 2003;29:89–109.

    Article  CAS  PubMed  Google Scholar 

  3. Palestro CJ, Torres MA. Radionuclide imaging in orthopedic infections. Semin Nucl Med 1997;27:334–345.

    Article  CAS  PubMed  Google Scholar 

  4. Rennen HJ, Boerman OC, Oyen WJ, Corstens FH. Imaging infection/inflammation in the new millennium. Eur J Nucl Med 2001;28:241–252.

    Article  CAS  PubMed  Google Scholar 

  5. Becker W, Meller J. The role of nuclear medicine in infection and inflammation. Lancet Infect Dis 2001;1:326–333.

    Article  CAS  PubMed  Google Scholar 

  6. Coleman RE. Clinical PET in oncology. Clin Positron Imaging 1998;1:15–30.

    Article  PubMed  Google Scholar 

  7. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972–1980.

    CAS  PubMed  Google Scholar 

  8. Alavi A, Gupta N, Alberini JL, Hickeson M, Adam LE, Bharqava P, et al. Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med 2002;32:293–321.

    Article  PubMed  Google Scholar 

  9. Beckers C, Ribbens C, André B, Marcelis S, Kaye O, Mathy L, et al. Assessment of disease activity in rheumatoid arthritis with 18F-FDG PET. J Nucl Med 2004;45:956–964.

    CAS  PubMed  Google Scholar 

  10. Beckers C, Jeukens X, Ribbens C, André B, Marcelis S, Leclercq P, et al. 18F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Eur J Nucl Med Mol Imaging 2006;33:275–280.

    Article  PubMed  Google Scholar 

  11. Umeda Y, Demura Y, Ishizaki T, Ameshima S, Miyamori I, Saito Y, et al. Dual-time-point 18F-FDG PET imaging for diagnosis of disease type and disease activity in patients with idiopathic interstitial pneumonia. Eur J Nucl Med Mol Imaging 2009;36:1121–1130.

    Article  PubMed  Google Scholar 

  12. Seldin DW, Habib I, Soudry G. Axillary lymph node visualization on F-18 FDG PET body scans in patients with rheumatoid arthritis. Clin Nucl Med 2007;32:524–526.

    Article  PubMed  Google Scholar 

  13. Nowak M, Carrasquillo JA, Yarboro CH, Bacharach SL, Whatley M, Valencia X, et al. A pilot study of the use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus. Arthritis Rheum 2004;50:1233–1238.

    Article  PubMed  Google Scholar 

  14. Fey GL, Jolles PR, Buckley LM, Massey GV. 2-Deoxy-2-[18F] fluoro-D-glucose positron emission tomography uptake in systemic lupus erythematosus-associated adenopathy. Mol Imaging Biol 2004;6:7–11.

    Article  PubMed  Google Scholar 

  15. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 2004;164:1275–1284.

    Article  PubMed  Google Scholar 

  16. Schwarz MI. The lung in polymyositis. Clin Chest Med 1998;19:701–712.

    Article  CAS  PubMed  Google Scholar 

  17. Harari OA, Al-Nahhas A, Jawad A. 18F-fluorodeoxyglucosepositron emission tomography imaging in idiopathic inflammatory myositis. Nucl Med Commun 2008;29:838–840.

    Article  PubMed  Google Scholar 

  18. Muñoz MA, Conejo-Mir JS, Congregado-Loscertales M, Holgado C, Moya F, Loscertales J. The utility of positron emission tomography to find an occult neoplasm in a patient with dermatomyositis. J Eur Acad Dermatol Venereol 2007;21:1418–1419.

    Article  PubMed  Google Scholar 

  19. Minai OA, Dweik RA, Arroliga AC. Manifestations of scleroderma pulmonary disease. Clin Chest Med 1998;19:713–731.

    Article  CAS  PubMed  Google Scholar 

  20. Ebert EC. Esophageal disease in scleroderma. J Clin Gastroenterol 2006;40:769–775.

    Article  PubMed  Google Scholar 

  21. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 1990;33:1101–1107.

    CAS  PubMed  Google Scholar 

  22. Chen W, Bural GG, Torigian DA, Rader DJ, Alavi A. Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 2009;36:144–151.

    Article  PubMed  Google Scholar 

  23. Webb M, Chambers A, AL-Nahhas A, Mason JC, Maudlin L, Rahman L, et al. The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 2004;31:627–634.

    Article  PubMed  Google Scholar 

  24. Arlet JB, Le Thi Huong DB, Pouchot J, Piette JC. Current concepts on the physiopathology of adult-onset Still’s disease. Rev Med Interne 2005;26:549–556.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan

    Yoshihiro Nishiyama & Yuka Yamamoto

  2. First Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan

    Hiroaki Dobashi & Tomohiro Kameda

Authors
  1. Yoshihiro Nishiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuka Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroaki Dobashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tomohiro Kameda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshihiro Nishiyama.

About this article

Cite this article

Nishiyama, Y., Yamamoto, Y., Dobashi, H. et al. Clinical value of 18F-fluorodeoxyglucose positron emission tomography in patients with connective tissue disease. Jpn J Radiol 28, 405–413 (2010). https://doi.org/10.1007/s11604-010-0445-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-010-0445-x

Key words

Search

Navigation